These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17192018)

  • 1. Synthesis of novel N1-substituted bicyclic pyrazole amino acids and evaluation of their interaction with glutamate receptors.
    Conti P; Grazioso G; di Ventimiglia SJ; Pinto A; Roda G; Madsen U; Bräuner-Osborne H; Nielsen B; Costagli C; Galli A
    Chem Biodivers; 2005 Jun; 2(6):748-57. PubMed ID: 17192018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
    Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
    J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids.
    Conti P; De Amici M; Joppolo Di Ventimiglia S; Stensbøl TB; Madsen U; Bräuner-Osborne H; Russo E; De Sarro G; Bruno G; De Micheli C
    J Med Chem; 2003 Jul; 46(14):3102-8. PubMed ID: 12825948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-hydroxy-1,2,5-oxadiazol-3-yl moiety as bioisoster of the carboxy function. Synthesis, ionization constants, and molecular pharmacological characterization at ionotropic glutamate receptors of compounds related to glutamate and its homologues.
    Lolli ML; Giordano C; Pickering DS; Rolando B; Hansen KB; Foti A; Contreras-Sanz A; Amir A; Fruttero R; Gasco A; Nielsen B; Johansen TN
    J Med Chem; 2010 May; 53(10):4110-8. PubMed ID: 20408529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, total synthesis, and biological evaluation of neodysiherbaine A derivative as potential probes.
    Sasaki M; Tsubone K; Shoji M; Oikawa M; Shimamoto K; Sakai R
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5784-7. PubMed ID: 16949819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of novel pyrrolo[3,4-d]pyrazole-dicarboxylic acids and evaluation of their interaction with glutamate receptors.
    Conti P; di Ventimiglia SJ; Pinto A; Tamborini L; Menniti FS; Lazzaro JT; De Micheli C
    Chem Biodivers; 2008 Apr; 5(4):657-63. PubMed ID: 18421758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate receptor activation: a four-step program.
    Miller C
    Science; 1998 Jun; 280(5369):1547-8. PubMed ID: 9644020
    [No Abstract]   [Full Text] [Related]  

  • 8. Tetrazolyl isoxazole amino acids as ionotropic glutamate receptor antagonists: synthesis, modelling and molecular pharmacology.
    Frølund B; Greenwood JR; Holm MM; Egebjerg J; Madsen U; Nielsen B; Bräuner-Osborne H; Stensbøl TB; Krogsgaard-Larsen P
    Bioorg Med Chem; 2005 Sep; 13(18):5391-8. PubMed ID: 16043357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties.
    Monn JA; Valli MJ; Massey SM; Wright RA; Salhoff CR; Johnson BG; Howe T; Alt CA; Rhodes GA; Robey RL; Griffey KR; Tizzano JP; Kallman MJ; Helton DR; Schoepp DD
    J Med Chem; 1997 Feb; 40(4):528-37. PubMed ID: 9046344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design and enantioselective synthesis of (1R,4S,5R,6S)-3-azabicyclo[3.3.0]octane-4,6-dicarboxylic acid - a novel inhibitor at human glutamate transporter subtypes 1, 2, and 3.
    Bunch L; Nielsen B; Jensen AA; Bräuner-Osborne H
    J Med Chem; 2006 Jan; 49(1):172-8. PubMed ID: 16392801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric synthesis and receptor pharmacology of the group II mGlu receptor ligand (1S,2R,3R,5R,6S)-2-amino-3-hydroxy-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid-HYDIA.
    Woltering TJ; Adam G; Huguenin P; Wichmann J; Kolczewski S; Gatti S; Bourson A; Kew JN; Richards G; Kemp JA; Mutel V; Knoflach F
    ChemMedChem; 2008 Feb; 3(2):323-35. PubMed ID: 18058780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of a scaffold for iGluR ligands based on the structure of (-)-dysiherbaine.
    Cohen JL; Limon A; Miledi R; Chamberlin AR
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2189-94. PubMed ID: 16455241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The respective N-hydroxypyrazole analogues of the classical glutamate receptor ligands ibotenic acid and (RS)-2-amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic acid.
    Clausen RP; Hansen KB; Calí P; Nielsen B; Greenwood JR; Begtrup M; Egebjerg J; Bräuner-Osborne H
    Eur J Pharmacol; 2004 Sep; 499(1-2):35-44. PubMed ID: 15363949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new highly selective metabotropic excitatory amino acid agonist: 2-amino-4-(3-hydroxy-5-methylisoxazol-4-yl)butyric acid.
    Bräuner-Osborne H; Sløk FA; Skjaerbaek N; Ebert B; Sekiyama N; Nakanishi S; Krogsgaard-Larsen P
    J Med Chem; 1996 Aug; 39(16):3188-94. PubMed ID: 8759641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 5-substituted 1-pyrazolol analogues of ibotenic acid: synthesis and pharmacology at glutamate receptors.
    Jørgensen CG; Bräuner-Osborne H; Nielsen B; Kehler J; Clausen RP; Krogsgaard-Larsen P; Madsen U
    Bioorg Med Chem; 2007 May; 15(10):3524-38. PubMed ID: 17376693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heteroaryl analogues of AMPA. 2. Synthesis, absolute stereochemistry, photochemistry, and structure-activity relationships.
    Falch E; Brehm L; Mikkelsen I; Johansen TN; Skjaerbaek N; Nielsen B; Stensbøl TB; Ebert B; Krogsgaard-Larsen P
    J Med Chem; 1998 Jul; 41(14):2513-23. PubMed ID: 9651156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039).
    Rorick-Kehn LM; Johnson BG; Burkey JL; Wright RA; Calligaro DO; Marek GJ; Nisenbaum ES; Catlow JT; Kingston AE; Giera DD; Herin MF; Monn JA; McKinzie DL; Schoepp DD
    J Pharmacol Exp Ther; 2007 Apr; 321(1):308-17. PubMed ID: 17204749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular determinants of ligand discrimination in the glutamate-binding pocket of the NMDA receptor.
    Laube B; Schemm R; Betz H
    Neuropharmacology; 2004 Dec; 47(7):994-1007. PubMed ID: 15555634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biology of the conformationally restricted ACPD analogue, 2-aminobicyclo[2.1.1]hexane-2,5-dicarboxylic acid-I, a potent mGluR agonist.
    Kozikowski AP; Steensma D; Araldi GL; Tückmantel W; Wang S; Pshenichkin S; Surina E; Wroblewski JT
    J Med Chem; 1998 May; 41(10):1641-50. PubMed ID: 9572889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1H-cyclopentapyrimidine-2,4(1H,3H)-dione-related ionotropic glutamate receptors ligands. structure-activity relationships and identification of potent and Selective iGluR5 modulators.
    Butini S; Pickering DS; Morelli E; Coccone SS; Trotta F; De Angelis M; Guarino E; Fiorini I; Campiani G; Novellino E; Schousboe A; Christensen JK; Gemma S
    J Med Chem; 2008 Oct; 51(20):6614-8. PubMed ID: 18811139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.